The global bacterial and viral specimen collection market is predicted to be valued at USD 62.32 billion by 2029 from USD 30.77 billion in 2024, growing at a CAGR of 15.16% from 2024 to 2029.
The rising occurrence of bacterial and viral diseases such as influenza, tuberculosis, HIV, and hepatitis and emerging infectious diseases such as Zika, and Ebola need effective and efficient specimen collection, urbanization and rise in mortality contribute to the faster transmission of infectious diseases, people moving across region and countries require robust specimen collection for accurate diagnosis and tracking, the emergence of new pathogen and growing challenges of antibiotic resistance require effective specimen collection allow early detection, appropriate treatment and containment of potentially dangerous infection, hence this factor majorly boost the market growth in the upcoming years.
A variety of specimen collection kits can be created through partnerships between prominent performers and other organizations, such as research organizations or smaller firms. Due to the variety, healthcare professionals can select the best options for various sample kinds and testing methodologies. Strategic partnerships can aid in enlarging the distribution networks for these collection kits, hence increasing their geographic accessibility. This is especially crucial in areas with potential gaps in healthcare infrastructure. Hence this factor majorly boosts the market growth.
This increases demand for specimen collection kits made especially to handle these developments. To ensure the accuracy of test results, emerging infectious illnesses and developing diagnostic technologies frequently need specialized specimen collection approaches. Customized collection kits are created because of research-driven innovations to meet these objectives. Current research highlights the requirement for gathering diverse types of samples for thorough testing. The rising demand for diagnostic testing, several manufacturers have ramped up the production of viral specimen collection products globally, and key companies involved in the introduction of innovation to enable the error-free laboratory quality specimen collection to fuel the market growth during the forecast period.
When the specimen that was taken does not adequately reflect the presence of the pathogen, false-negative results may arise. Patient care and public health initiatives may be harmed because of a false diagnosis or a delay in treatment. Techniques for collecting samples that are improper or insufficient can result in samples that contain inadequate amounts of the target pathogen. As a result, even if the pathogen is present, the results can be falsely negative. Hence this factor majorly hampers the market growth during the projected period.
REPORT METRIC |
DETAILS |
Market Size Available |
2024 to 2029 |
Base Year |
2024 |
Forecast Period |
2024 to 2029 |
Segments Analysed |
Based on Type, Application, End-User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
Market Leaders Profiled |
The prominent key player in the global bacterial and viral specimen collection market are Puritan Medical Products, COPAN Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Quidel Corporation, Longhorn Vaccines and Diagnostics. |
Based on the type, the bacterial specimen collection segment has dominated the market with a notable share of 58.3% in 2024 and is anticipated to continue to dominate the market during the projected period. The high prevalence of tuberculosis is one of the major factors attributed to a larger share of this segment, as the rising prevalence of tuberculosis surges the diagnosis and adoption of different bacterial specimen-collecting products, boosting segmental growth.
The viral specimen collection segment is also anticipated to show lucrative growth in the market during the projected period. The increasing development in the detection of virus infection boosts segmental growth. For instance, the University of Rochester Medical Centre in Rochester, New York, created a finger-stick test in April 2022 that can identify more than 50 different flu strains from a few drops of blood. This test is being developed for clinical use. Rocky Mountain Biologicals also introduced the Viral Transport Medium for extensive infectious disease testing in May 2022. Hence this segment also propels the market growth during the forecast period.
Based on application, the diagnostic segment accounted for the major market share of 71% in 2022 for the viral and bacterial specimen collection, this is due to Strong diagnostic testing is required due to the rising incidence of bacterial and viral diseases, including both common and new infections. For effective treatment and illness management, early detection and precise diagnosis are essential. Healthcare professionals can customize therapies for specific patients with the aid of diagnostic testing, which aids in identifying the microorganism responsible for the disease and its characteristics. Hence this segment propels the market growth in upcoming years.
The research segment is also expected to hold a significant market share during the projected period. Studying the molecular, genetic, and metabolic causes of bacterial and viral illnesses requires effective specimen collection. To find the root causes of illnesses, researchers rely on samples that have been kept in good condition. Biomarkers molecules that show the existence of a disease or its progression are discovered by researchers via specimen collecting. The use of these biomarkers for diagnostic or prognostic purposes is possible.
Based on end-user, the hospital and clinic segment witness a major revenue share of 58.7% in 2022 and is expected to continue to dominate the market at a notable share during the projected period. The rising prevalence of infectious and viral diseases across the globe attribute to an increase in a patient with respiratory viruses and bacterial infection, furthermore, the rising cases of healthcare-associated infection in acute care hospital need proper medication hence this factor propels the segmental growth and boost the market growth in the upcoming years.
The diagnostic laboratories segment is also anticipated to hold a significant market share and grow at a healthy CAGR during the projected period.
Geographically, the North America region dominated the market with a revenue share of 47.7% in 2022. The rising prevalence of infectious diseases and increasing awareness among the population regarding the transmission of diseases, diagnosis, and effective management of infection observed in this region, leads to the higher adoption of the products, resulting in a earn more market revenue in this region. The growing government support and initiative taken by the government further fuel the market growth in this region.
APAC region is expected to show lucrative growth and grow at the highest CAGR during the projected period. A significant majority of the world's population resides in the APAC region, which includes populated nations like China and India. The need for efficient specimen-collecting techniques to enable precise diagnosis and disease surveillance is driven by the huge and expanding population. Because of factors including urbanization, interactions between species and people, and modifications in agricultural procedures, and the APAC region is especially vulnerable to the introduction of novel infectious illnesses. To facilitate research and diagnoses, better specimen collection techniques are required in this region and propel the market growth.
Europe is another region expected to grow at a healthy CAGR during the projected period. Europe is renowned for having advanced infrastructure and healthcare systems. The need for high-quality specimen collection techniques to promote accurate and prompt illness diagnosis is driven by the accessibility of contemporary healthcare facilities and diagnostics. A large portion of the population in the area is getting older, making them more susceptible to bacterial and viral diseases. This increases the need for efficient specimen-collecting techniques to support monitoring and diagnostics in older people, hence this region also fuel the market growth in the upcoming years.
Latin America and the Middle East and Africa region predicted to show lucrative growth and grow at a significant CAGR during the forecast period.
The prominent key player in the global bacterial and viral specimen collection market are Puritan Medical Products, COPAN Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Quidel Corporation, Longhorn Vaccines and Diagnostics, LLC, Pretium Packaging, Trinity Biotech, Medical Wire & Equipment, HiMedia Laboratories, Hardy Diagnostics, Nest Scientific, VIRCELL S.L., DiaSorin, Titan Biotech.
Frequently Asked Questions
The market has seen advancements in specimen collection techniques, materials, and devices. There's a growing demand for user-friendly, non-invasive collection methods and an increasing focus on preserving sample integrity during transportation and storage.
Factors include the rising prevalence of infectious diseases, increasing awareness about early disease diagnosis, technological advancements in collection devices, and the expansion of healthcare infrastructure globally.
Challenges include maintaining consistent product quality, ensuring proper training for healthcare professionals on correct collection techniques, and addressing cultural or geographical factors that might affect specimen collection.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region